Uncoupling protein 1-independent effects of eicosapentaenoic acid in brown adipose tissue of diet-induced obese female mice.
Adipose Tissue, Brown
/ metabolism
Animals
Body Weight
/ drug effects
Diet, High-Fat
/ adverse effects
Eicosapentaenoic Acid
/ pharmacology
Energy Metabolism
/ drug effects
Female
Glucose Intolerance
/ metabolism
Glucose Tolerance Test
/ methods
Mice
Mice, Knockout
Mice, Obese
Obesity
/ drug therapy
Temperature
Thermogenesis
/ drug effects
Uncoupling Protein 1
/ metabolism
Brown adipose tissue
Eicosapentaenoic acid
Female mice
Obesity
Thermoneutrality
Uncoupling protein 1
Journal
The Journal of nutritional biochemistry
ISSN: 1873-4847
Titre abrégé: J Nutr Biochem
Pays: United States
ID NLM: 9010081
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
01
10
2020
revised:
29
04
2021
accepted:
30
06
2021
pubmed:
17
7
2021
medline:
3
3
2022
entrez:
16
7
2021
Statut:
ppublish
Résumé
Brown adipose tissue (BAT) plays a key role in energy expenditure through its thermogenic function, making its activation a popular target to reduce obesity. We recently reported that male mice housed at thermoneutrality with uncoupling protein 1 (UCP1) deficiency had increased weight gain and glucose intolerance, but eicosapentaenoic acid (EPA) ameliorated these effects. Whether female mice respond similarly to lack of UCP1 and to EPA remains unknown. We hypothesize that the effects of EPA on BAT activation are independent of UCP1 expression. We used female wild type (WT) and UCP1 knockout (KO) mice housed at thermoneutrality (30°C) as an obesogenic environment and fed them high fat (HF) diets with or without EPA for up to 14 weeks. Body weight (BW), body composition, and insulin and glucose tolerance tests were performed during the feeding trial. At termination, serum and BAT were harvested for further analyses. Mice in the KO-EPA group had significantly lower BW than KO-HF mice. In addition, KO-HF mice displayed significantly impaired glucose tolerance compared to their WT-HF littermates. However, EPA significantly enhanced glucose clearance in the KO mice compared to KO-HF mice. Protein levels of the mitochondrial cytochrome C oxidase subunits I, II, and IV were significantly lower in KO mice compared to WT. Our findings support that ablation of UCP1 is detrimental to energy metabolism of female mice in thermoneutral conditions. However, unexpectedly, EPA's protective effects against diet-induced obesity and glucose intolerance in these mice were independent of UCP1.
Identifiants
pubmed: 34271101
pii: S0955-2863(21)00239-4
doi: 10.1016/j.jnutbio.2021.108819
pmc: PMC8571038
mid: NIHMS1732684
pii:
doi:
Substances chimiques
Uncoupling Protein 1
0
Eicosapentaenoic Acid
AAN7QOV9EA
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
108819Subventions
Organisme : NCCIH NIH HHS
ID : R15 AT008879
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Références
Lipids Health Dis. 2017 Jul 3;16(1):131
pubmed: 28673352
Am J Public Health. 2013 Oct;103(10):1895-901
pubmed: 23948004
FASEB J. 2009 Jun;23(6):1946-57
pubmed: 19211925
Food Funct. 2017 Apr 19;8(4):1481-1493
pubmed: 28327709
Prog Lipid Res. 2011 Oct;50(4):372-87
pubmed: 21762726
Am J Physiol Endocrinol Metab. 2013 Jun 15;304(12):E1391-403
pubmed: 23632634
Cell Physiol Biochem. 2007;19(1-4):195-204
pubmed: 17310113
Diabetes Care. 2015 Aug;38(8):1567-82
pubmed: 26421334
Heart Metab. 2016 Mar;69:9-14
pubmed: 27524955
J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):655-73
pubmed: 25315926
Mol Nutr Food Res. 2019 Apr;63(7):e1800821
pubmed: 30657255
Diabetes. 2015 Jul;64(7):2352-60
pubmed: 26050667
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):7981-7986
pubmed: 28630339
Sci Rep. 2015 Dec 17;5:18013
pubmed: 26673120
Physiol Res. 2013;62(2):153-61
pubmed: 23234412
Prostaglandins Leukot Essent Fatty Acids. 2018 Sep;136:47-55
pubmed: 29113747
Cell Metab. 2009 Feb;9(2):203-9
pubmed: 19187776
J Biol Chem. 2007 Apr 20;282(16):12240-8
pubmed: 17322303
Eur J Nutr. 2016 Feb;55(1):159-69
pubmed: 25612928
Nat Med. 2017 Dec;23(12):1454-1465
pubmed: 29131158
Cell Metab. 2016 Apr 12;23(4):602-9
pubmed: 26972823
J Nutr. 2010 Nov;140(11):1915-22
pubmed: 20861209
Semin Immunopathol. 2019 Nov;41(6):757-766
pubmed: 31696250
Am J Physiol Regul Integr Comp Physiol. 2017 Jan 1;312(1):R74-R84
pubmed: 27881400
Am J Clin Nutr. 1997 May;65(5 Suppl):1645S-1654S
pubmed: 9129504
Pflugers Arch. 2016 Sep;468(9):1527-40
pubmed: 27318696
Eur Rev Med Pharmacol Sci. 2015;19(3):441-5
pubmed: 25720716
Am J Physiol. 1986 Nov;251(5 Pt 1):E576-83
pubmed: 3535532
J Clin Invest. 2013 Jan;123(1):215-23
pubmed: 23221344
Cell Rep. 2013 Dec 12;5(5):1196-203
pubmed: 24290753
Dtsch Arztebl Int. 2014 Oct 17;111(42):705-13
pubmed: 25385482
J Lipid Res. 2016 Aug;57(8):1382-97
pubmed: 27307576
Am J Clin Nutr. 1997 Sep;66(3):649-59
pubmed: 9280188
PLoS One. 2011 Mar 02;6(3):e17504
pubmed: 21407809
J Nutr Biochem. 2017 Jan;39:101-109
pubmed: 27833050
Obesity (Silver Spring). 2010 Mar;18(3):463-9
pubmed: 19730425
Cell. 2012 Oct 12;151(2):400-13
pubmed: 23063128
Cell. 2015 Oct 22;163(3):643-55
pubmed: 26496606
Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E444-52
pubmed: 17473055
Diabetes. 2009 Apr;58(4):803-12
pubmed: 19136652
Int J Obes (Lond). 2015 Oct;39(10):1539-47
pubmed: 26032810
P T. 2013 Nov;38(11):681-91
pubmed: 24391388
Prev Nutr Food Sci. 2017 Dec;22(4):251-262
pubmed: 29333376
Lancet. 1989 Sep 30;2(8666):757-61
pubmed: 2571009
Mol Metab. 2018 Jan;7:161-170
pubmed: 29122558
EMBO Rep. 2016 Mar;17(3):383-99
pubmed: 26882545
Am J Physiol Endocrinol Metab. 2020 Nov 1;319(5):E944-E946
pubmed: 32954822
J Nutr. 2015 Mar;145(3):411-7
pubmed: 25733455
Channels (Austin). 2017 Mar 4;11(2):94-96
pubmed: 27573536
NCHS Data Brief. 2017 Oct;(288):1-8
pubmed: 29155689
Prog Biophys Mol Biol. 2006 Jan-Apr;90(1-3):299-325
pubmed: 16005051
Int J Mol Med. 2009 Jul;24(1):125-9
pubmed: 19513544
J Clin Invest. 2003 Feb;111(3):399-407
pubmed: 12569166